REDUCEDT+7
Hrti Private Limited
Shukra Pharmaceuticals Ltd · NSE
−33,95,277 sh · ₹23.49 Cr
Filed 5 Oct 2026NSE bulk dealview source
FII holding ~flat QoQ
Jun 2026 quarter
Ownership by quarter
Promoter
— 0.0pp
Promoter holding by quarter: Sep 2025 51.0%, Dec 2025 51.0%, Mar 2026 51.0%.
FII
— 0.0pp
FII holding by quarter: Sep 2025 0.0%, Dec 2025 0.0%, Mar 2026 0.0%.
DII
— 0.0pp
DII holding by quarter: Sep 2025 0.1%, Dec 2025 0.1%, Mar 2026 0.1%.
Hrti Private Limited
Shukra Pharmaceuticals Ltd · NSE
−33,95,277 sh · ₹23.49 Cr
Qe Securities LLP
Shukra Pharmaceuticals Ltd · NSE
+31,07,889 sh · ₹21.38 Cr
Hrti Private Limited
Shukra Pharmaceuticals Ltd · NSE
+37,00,565 sh · ₹25.62 Cr
Alphagrep Securities Private Limited
Shukra Pharmaceuticals Ltd · NSE
−29,60,423 sh · ₹20.33 Cr
Qe Securities LLP
Shukra Pharmaceuticals Ltd · NSE
−31,62,310 sh · ₹21.85 Cr
Alphagrep Securities Private Limited
Shukra Pharmaceuticals Ltd · NSE
+29,60,423 sh · ₹20.32 Cr
The announcements library is part of Pro.
Every exchange filing this company makes — results, board meetings, dividends, analyst meets, investor presentations — as filed with NSE / BSE, the day it lands.
42 announcements on record for this company.
MF
— 0.0pp
MF holding by quarter: Sep 2025 0.0%, Dec 2025 0.0%, Mar 2026 0.0%.
Per-series scale, bounds labeled. Gaps mark quarters without a filing.
Ownership by quarter
Promoter
— 0.0pp
Promoter holding by quarter: Sep 2025 51.0%, Dec 2025 51.0%, Mar 2026 51.0%.
FII
— 0.0pp
FII holding by quarter: Sep 2025 0.0%, Dec 2025 0.0%, Mar 2026 0.0%.
DII
— 0.0pp
DII holding by quarter: Sep 2025 0.1%, Dec 2025 0.1%, Mar 2026 0.1%.
MF
— 0.0pp
MF holding by quarter: Sep 2025 0.0%, Dec 2025 0.0%, Mar 2026 0.0%.
Per-series scale, bounds labeled. Gaps mark quarters without a filing.
The announcements library is part of Pro.
Every exchange filing this company makes — results, board meetings, dividends, analyst meets, investor presentations — as filed with NSE / BSE, the day it lands.
42 announcements on record for this company.